Pharmaceutical Market Europe
@PMLiVEcom
Followers
16K
Following
358
Media
635
Statuses
21K
News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.
Surrey, UK
Joined June 2009
Roche’s Evrysdi tablets approved by MHRA to treat spinal muscular atrophy
pmlive.com
It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version
0
0
0
In PME's latest thought leadership piece, Becky Paul from Bionical Solutions explores how patient activation is not just a strategy, but a necessity in today’s healthcare landscape: #PatientActivation #HealthcareComms #PersonalisedCare #Pharma #PME.
pmlive.com
By Becky Paul
0
0
0
Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process
pmlive.com
Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health...
0
0
0
AstraZeneca’s Imfinzi/Imjudo regimen recommended by NICE to treat liver cancer
pmlive.com
Approximately 6,600 people are diagnosed with liver cancer every year in the UK
0
0
2
Check out PME's latest thought leadership piece by Stephen O’Farrell from Aurora Healthcare Communications on the patient engagement value equation: #PatientEngagement #HealthcareComms #Pharma #Health #PME.
pmlive.com
By Stephen O’Farrell
0
0
0
CHMP recommends BeOne Medicines’ Tevimbra for new lung cancer indication
pmlive.com
Non-small cell lung cancer accounts for up to 90% of all lung cancer cases
0
0
1
BMS and Bain Capital launch new company to develop immunology therapies
pmlive.com
The newly formed company has in-licensed five investigational immunology drugs from BMS
0
0
0
Check out PME's latest thought leadership piece by Carol Pitcher-Towner from Alnylam Pharmaceuticals on the importance of representation, innovation and trust in rare disease clinical trials: #RareDiseases #ClinicalResearch #HealthEquity #Pharma #PME.
pmlive.com
By Carol Pitcher-Towner
1
0
1
The power of representation, innovation and trust in rare disease clinical trials
pmlive.com
By Carol Pitcher-Towner
1
0
0
In his latest article in PME, Danny Buckland explores how listening to patients can help deliver meaningful patient involvement and health activation: #PatientEngagement #PatientActivation #Pharma #Health #PME.
pmlive.com
Listening to patients and HCPs helps strike the right notes to deliver harmony across engagement and activation
0
0
0
FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata
pmlive.com
Approximately 700,000 people in the US currently have some form of the autoimmune disease
0
0
0
Biogen’s Qalsody granted MHRA approval to treat rare form of motor neurone disease
pmlive.com
Mutations in the SOD1 gene are responsible for approximately 2% of all cases of the disease
1
0
0
Designing with patients in mind: How to build more inclusive clinical trials
pmlive.com
Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.
0
0
0
Three Key Trends Shaping the Future of Clinical Trials
pmlive.com
So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.
0
0
0
The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks
pmlive.com
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust...
0
0
1
Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years
pmlive.com
Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and...
0
0
1
Patient engagement – a journey of health activation
pmlive.com
Listening to patients and HCPs helps strike the right notes to deliver harmony across engagement and activation
0
0
0
Eli Lilly’s Alzheimer’s disease drug donanemab recommended by CHMP
pmlive.com
Up to 6.9 million people in Europe are affected by the neurodegenerative disorder
0
0
0